<DOC>
	<DOCNO>NCT01614171</DOCNO>
	<brief_summary>Osteoporosis pseudoglioma ( OPPG ) syndrome rare autosomal recessive condition childhood osteoporosis congenital blindness new treatment need . We find body fat increase OPPG muscle mass reduce . We hypothesize growth hormone therapy improve muscle mass bone strength OPPG .</brief_summary>
	<brief_title>Growth Hormone Osteoporosis Pseudoglioma Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteogenesis Imperfecta</mesh_term>
	<mesh_term>Blindness</mesh_term>
	<mesh_term>Spasms , Infantile</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Osteoporosis pseudoglioma syndrome Age 4 year medication osteoporosis pregnant Age 4 yrs Active malignancy</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>osteoporosis pseudoglioma</keyword>
	<keyword>OPPG</keyword>
	<keyword>growth hormone</keyword>
	<keyword>osteoporosis</keyword>
</DOC>